Fundz

Who to call at NLS Pharmaceutics Ltd, and when

Fundz watches for the moments NLS Pharmaceutics Ltd starts buying, and tells you who to reach.

  • An alert the day NLS Pharmaceutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NLS Pharmaceutics Ltd, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

NLS Pharmaceutics and Kadimastem Announce Initial Closing of $500,000 Fundraising Effort for Merger

Jan 08, 2025

Contract Type

partnership

ZurichManufacturingBiotechnologyHealthcareHealth CareTherapeutics

Description

NLS Pharmaceutics Ltd. and Kadimastem Ltd. have announced the initial closing of a $500,000 fundraising initiative, marking the first step in a larger $1 million fundraising round to facilitate a proposed merger between the two companies. The merger aims to create a Nasdaq-traded biotechnology company with advanced-stage product candidates, significantly strengthening their strategic position in the biotechnology sector

Company Information

Company

NLS Pharmaceutics Ltd

Location

THE CIRCLE 6

Zurich, Zurich, Switzerland

About

NLS Pharmaceutics is a biopharmaceutical company that specializes in developing innovative therapies for patients with central nervous system disorders. The company's focus includes a diversified pipeline aimed at addressing serious unmet medical needs. It aims to improve the lives of patients through advanced drug delivery systems and small-molecule expertise.

Related People

Alex
Senior decision-maker at this company
••••••••@••••••••

See Alex's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for NLS Pharmaceutics Ltd's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

NLS Pharmaceutics Ltd signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.